1. Home
  2. JYNT vs ZOM Comparison

JYNT vs ZOM Comparison

Compare JYNT & ZOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • ZOM
  • Stock Information
  • Founded
  • JYNT 2010
  • ZOM 2015
  • Country
  • JYNT United States
  • ZOM United States
  • Employees
  • JYNT N/A
  • ZOM N/A
  • Industry
  • JYNT Multi-Sector Companies
  • ZOM Biotechnology: Pharmaceutical Preparations
  • Sector
  • JYNT Miscellaneous
  • ZOM Health Care
  • Exchange
  • JYNT Nasdaq
  • ZOM Nasdaq
  • Market Cap
  • JYNT 154.2M
  • ZOM 135.9M
  • IPO Year
  • JYNT 2014
  • ZOM N/A
  • Fundamental
  • Price
  • JYNT $10.30
  • ZOM $0.12
  • Analyst Decision
  • JYNT Strong Buy
  • ZOM
  • Analyst Count
  • JYNT 2
  • ZOM 0
  • Target Price
  • JYNT $17.50
  • ZOM N/A
  • AVG Volume (30 Days)
  • JYNT 37.2K
  • ZOM 5.1M
  • Earning Date
  • JYNT 11-07-2024
  • ZOM 11-07-2024
  • Dividend Yield
  • JYNT N/A
  • ZOM N/A
  • EPS Growth
  • JYNT N/A
  • ZOM N/A
  • EPS
  • JYNT N/A
  • ZOM N/A
  • Revenue
  • JYNT $120,795,620.00
  • ZOM $26,727,000.00
  • Revenue This Year
  • JYNT $3.28
  • ZOM $36.75
  • Revenue Next Year
  • JYNT N/A
  • ZOM $14.92
  • P/E Ratio
  • JYNT N/A
  • ZOM N/A
  • Revenue Growth
  • JYNT 5.26
  • ZOM 11.33
  • 52 Week Low
  • JYNT $8.88
  • ZOM $0.12
  • 52 Week High
  • JYNT $17.82
  • ZOM $0.23
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 33.35
  • ZOM 39.71
  • Support Level
  • JYNT $11.31
  • ZOM $0.12
  • Resistance Level
  • JYNT $11.20
  • ZOM $0.12
  • Average True Range (ATR)
  • JYNT 0.37
  • ZOM 0.00
  • MACD
  • JYNT -0.14
  • ZOM -0.00
  • Stochastic Oscillator
  • JYNT 15.34
  • ZOM 10.59

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

About ZOM Zomedica Corp.

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.

Share on Social Networks: